Congenital Myasthenic Syndromes (CMS) are a group of rare genetic disorders that affect the neuromuscular junction, leading to muscle weakness and fatigue. These syndromes are caused by mutations ...

Congenital myasthenic syndromes (CMSs) are a heterogeneous group of disorders that affect the safety margin of neuromuscular transmission — the depolarization that is required for propagation of ...

Oppenheimer reaffirmed its positive stance on Catalyst Pharmaceutical (TADAWUL:2070) Partners (NASDAQ:CPRX), maintaining an Outperform rating and a price target of $31.00. According to InvestingPro ...

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ...